Supernus Pharmaceuticals (SUPN) Return on Capital Employed Growth (3y) (2015 - 2026)
Supernus Pharmaceuticals (SUPN) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | -1,143.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,143.00 |
| Dec 31, 2025 | -1,024.00 |
| Sep 30, 2025 | -530.00 |
| Jun 30, 2025 | 36.00 |
| Mar 31, 2025 | 151.00 |
| Dec 31, 2024 | 110.00 |
| Sep 30, 2024 | -354.00 |
| Jun 30, 2024 | -900.00 |
| Mar 31, 2024 | -1,257.00 |
| Dec 31, 2023 | -1,392.00 |
| Sep 30, 2023 | -3,337.00 |
| Mar 31, 2023 | -1,026.00 |
| Dec 31, 2022 | -1,070.00 |
| Sep 30, 2022 | -1,393.00 |
| Jun 30, 2022 | -1,056.00 |
| Mar 31, 2022 | -1,087.00 |
| Dec 31, 2021 | -1,173.00 |
| Sep 30, 2021 | -929.00 |
| Jun 30, 2021 | -519.00 |
| Mar 31, 2021 | -1,140.00 |